Earnings Alerts

Alchip Technologies (3661) Earnings Surge with September Sales Boosting 82.6%

  • Alchip Technologies reported sales of NT$5.30 billion in September 2024.
  • This represents an increase of 82.6% compared to the previous period.
  • The company’s stock ratings include 17 buy recommendations, 2 hold ratings, and 1 sell recommendation.

A look at Alchip Technologies Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth5
Resilience5
Momentum2
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Alchip Technologies shows strong potential for long-term growth and resilience. With a Growth score of 5 and a Resilience score of 5, the company is positioned well for future development and the ability to withstand challenges in the market. Alchip specializes in silicon design and manufacturing services, catering to various industries such as consumer electronics, optical networking, and medical imaging equipment.

Although Alchip Technologies scored lower in terms of Value and Momentum, with scores of 2 for both factors, the emphasis on growth and resilience signals a positive long-term outlook for the company. Investors may find potential value in Alchip given its focus on innovation and ability to adapt to changing market conditions. With a diversified customer base worldwide, Alchip Technologies is well poised to capitalize on emerging opportunities in the semiconductor industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars